Author | Gary H. Lyman, MD, MPH | OncLive

Author | Gary H. Lyman, MD, MPH

Articles

Dr. Lyman on G-CSF Biosimilars and Potential Impact on the Market

October 01, 2019

Video

Gary H. Lyman, MD, MPH, discusses granulocyte colony-stimulating factor biosimilars and their impact on the market.

Dr. Lyman on Challenges with Biosimilar Policies

September 25, 2019

Video

Gary H. Lyman, MD, MPH, discusses challenges in biosimilar policies.

Dr. Lyman on Rituximab Biosimilars in Non-Hodgkin Lymphoma

September 19, 2019

Video

Gary H. Lyman, MD, MPH, senior lead, Health Care Quality and Policy, Hutchinson Institute for Cancer Outcomes Research, member, Cancer Prevention Program, Public Health Services Division, and member, Clinical Research Division, Fred Hutchinson Cancer Research Center, discusses the use of rituximab (Rituxan) biosimilars in the treatment of patients with non-Hodgkin lymphoma (NHL).

Dr. Lyman on Educational Initiatives Regarding the Use of Biosimilars in Oncology

September 12, 2019

Video

Gary H. Lyman, MD, MPH, senior lead, Health Care Quality and Policy, Hutchinson Institute for Cancer Outcomes Research, member, Cancer Prevention Program, Public Health Services Division, and member, Clinical Research Division, Fred Hutchinson Cancer Research Center, discusses educational initiatives regarding the use of biosimilars in oncology.

x